Incidence of Extraarticular Rheumatoid Arthritis in Olmsted County, Minnesota, in 1995-2007 Versus 1985-1994: a Population-based Study

Overview

Journal J Rheumatol

Specialty Rheumatology

Date 2011 Apr 5

PMID 21459933

Citations 68

Authors

Elena Myasoedova

Cynthia S Crowson

Carl Turesson

Sherine E Gabriel

Eric L Matteson

Affiliations

Soon will be listed here.

Abstract

Objective: To assess incidence and mortality effects of extraarticular rheumatoid arthritis (ExRA) in patients with incident RA in 1995-2007 compared to 1985-1994, in Olmsted County, Minnesota, USA.

Methods: Data on incident ExRA were abstracted from medical records of patients with RA - Olmsted County residents who first met the 1987 American College of Rheumatology criteria for RA between January 1, 1995, and December 31, 2007. Patients were followed until death, migration from Olmsted County, or December 31, 2008. ExRA were classified using the predefined criteria and compared to the corresponding 1985-1994 inception RA cohort (n = 147).

Results: The 1995-2007 cohort included 463 patients with RA followed for a mean of 6.3 years; mean age was 55.6 years, 69% were women, 67% were positive for rheumatoid factor (RF). The 10-year cumulative incidence of any ExRA (50.1%) and severe ExRA (6.7%) in the 1995-2007 cohort was similar to the 1985-1994 cohort (46.2% and 9.7%, respectively). The 10-year cumulative incidence of vasculitis, but not other features of ExRA, was significantly lower in the 1995-2007 cohort (0.6%) compared to the 1985-1994 cohort (3.6%). RF positivity, erosions/destructive changes, and use of methotrexate, other disease-modifying antirheumatic drugs and systemic corticosteroids were significantly associated with ExRA in the 1995-2007 cohort. ExRA was associated with mortality risk (HR 2.1, 95% CI 1.2, 3.7) in the 1995-2007 cohort. The decrease in mortality following ExRA in the 1995-2007 cohort versus the 1985-1994 cohort did not reach statistical significance (HR 0.6, 95% CI 0.3, 1.2, p = 0.16).

Conclusion: ExRA remains a common complication associated with increased mortality in RA. The occurrence of vasculitis appears to be decreasing in recent years.

Citing Articles

Differences in rates of remission between rheumatoid factor positive and negative rheumatoid arthritis patients: experience from a resource-limited setting.

Tasamma A, Eshetu B, Seyoum A, Woldegiorgis S, Wolle M, Shumye G Clin Rheumatol. 2025; .

PMID: 40000560 DOI: 10.1007/s10067-025-07370-7.

Immunomodulatory Effects of SGLT2 Inhibitors and Metformin in Managing Rheumatic Diseases: A Narrative Review.

Nallathambi N, Bisaralli R, Mamadapur M Mediterr J Rheumatol. 2024; 35(3):411-421.

PMID: 39463877 PMC: 11500115. DOI: 10.31138/mjr.010324.ies.

Acupuncture treatment is associated with a decreased risk of dementia in patients with rheumatoid arthritis in Taiwan: A propensity-score matched cohort study.

Liao H, Huang M, Lee Y, Lin C, Wu M, Mayer P Integr Med Res. 2024; 13(4):101086.

PMID: 39399823 PMC: 11465145. DOI: 10.1016/j.imr.2024.101086.

Anti TNF-Alpha Treatment Improves Microvascular Endothelial Dysfunction in Rheumatoid Arthritis Patients.

Caraba A, Stancu O, Crisan V, Georgescu D Int J Mol Sci. 2024; 25(18).

PMID: 39337413 PMC: 11432218. DOI: 10.3390/ijms25189925.

Medical Ozone: A Redox Regulator with Selectivity for Rheumatoid Arthritis Patients.

Leon Fernandez O, Oru G, Viebahn-Haensler R, Lopez Cabreja G, Serrano Espinosa I, Corrales Vazquez M Pharmaceuticals (Basel). 2024; 17(3).

PMID: 38543177 PMC: 10975283. DOI: 10.3390/ph17030391.

References

Carmona L, Gonzalez-Alvaro I, Balsa A, Angel Belmonte M, Tena X, Sanmarti R . Rheumatoid arthritis in Spain: occurrence of extra-articular manifestations and estimates of disease severity. Ann Rheum Dis. 2003; 62(9):897-900. PMC: 1754657. DOI: 10.1136/ard.62.9.897. View

Watts R, Mooney J, Lane S, Scott D . Rheumatoid vasculitis: becoming extinct?. Rheumatology (Oxford). 2004; 43(7):920-3. DOI: 10.1093/rheumatology/keh210. View

Calguneri M, Ureten K, Ozturk M, Onat A, Ertenli I, Kiraz S . Extra-articular manifestations of rheumatoid arthritis: results of a university hospital of 526 patients in Turkey. Clin Exp Rheumatol. 2006; 24(3):305-8. View

Bartels C, Bell C, Shinki K, Rosenthal A, Bridges A . Changing trends in serious extra-articular manifestations of rheumatoid arthritis among United State veterans over 20 years. Rheumatology (Oxford). 2010; 49(9):1670-5. PMC: 2919197. DOI: 10.1093/rheumatology/keq135. View

Puechal X, Miceli-Richard C, Mejjad O, Lafforgue P, Marcelli C, Solau-Gervais E . Anti-tumour necrosis factor treatment in patients with refractory systemic vasculitis associated with rheumatoid arthritis. Ann Rheum Dis. 2007; 67(6):880-4. DOI: 10.1136/ard.2007.081679. View

Gabriel S, Crowson C, Kremers H, Doran M, Turesson C, OFallon W . Survival in rheumatoid arthritis: a population-based analysis of trends over 40 years. Arthritis Rheum. 2003; 48(1):54-8. DOI: 10.1002/art.10705. View

Turesson C, McClelland R, Christianson T, Matteson E . No decrease over time in the incidence of vasculitis or other extraarticular manifestations in rheumatoid arthritis: results from a community-based study. Arthritis Rheum. 2004; 50(11):3729-31. DOI: 10.1002/art.20590. View

Ward M . Decreases in rates of hospitalizations for manifestations of severe rheumatoid arthritis, 1983-2001. Arthritis Rheum. 2004; 50(4):1122-31. DOI: 10.1002/art.20158. View

Welsing P, Fransen J, van Riel P . Is the disease course of rheumatoid arthritis becoming milder? Time trends since 1985 in an inception cohort of early rheumatoid arthritis. Arthritis Rheum. 2005; 52(9):2616-24. DOI: 10.1002/art.21259. View

10.

Odegard S, Kvien T, Uhlig T . Incidence of clinically important 10-year health status and disease activity levels in population-based cohorts with rheumatoid arthritis. J Rheumatol. 2007; 35(1):54-60. View

11.

Nyhall-Wahlin B, Petersson I, Nilsson J, Jacobsson L, Turesson C . High disease activity disability burden and smoking predict severe extra-articular manifestations in early rheumatoid arthritis. Rheumatology (Oxford). 2009; 48(4):416-20. DOI: 10.1093/rheumatology/kep004. View

12.

Turesson C, Jacobsson L, Bergstrom U . Extra-articular rheumatoid arthritis: prevalence and mortality. Rheumatology (Oxford). 1999; 38(7):668-74. DOI: 10.1093/rheumatology/38.7.668. View

13.

Kremers H, Crowson C, Gabriel S . Rochester Epidemiology Project: a unique resource for research in the rheumatic diseases. Rheum Dis Clin North Am. 2004; 30(4):819-34, vii. DOI: 10.1016/j.rdc.2004.07.010. View

14.

Turesson C, Eberhardt K, Jacobsson L, Lindqvist E . Incidence and predictors of severe extra-articular disease manifestations in an early rheumatoid arthritis inception cohort. Ann Rheum Dis. 2007; 66(11):1543-4. PMC: 2111628. DOI: 10.1136/ard.2007.076521. View

15.

Pincus T, Sokka T, Kautiainen H . Patients seen for standard rheumatoid arthritis care have significantly better articular, radiographic, laboratory, and functional status in 2000 than in 1985. Arthritis Rheum. 2005; 52(4):1009-19. DOI: 10.1002/art.20941. View

16.

Turesson C, OFallon W, Crowson C, Gabriel S, Matteson E . Occurrence of extraarticular disease manifestations is associated with excess mortality in a community based cohort of patients with rheumatoid arthritis. J Rheumatol. 2002; 29(1):62-7. View

17.

Hellmann M, Jung N, Owczarczyk K, Hallek M, Rubbert A . Successful treatment of rheumatoid vasculitis-associated cutaneous ulcers using rituximab in two patients with rheumatoid arthritis. Rheumatology (Oxford). 2008; 47(6):929-30. DOI: 10.1093/rheumatology/ken129. View

18.

Cimmino M, Salvarani C, Macchioni P, Montecucco C, Fossaluzza V, Mascia M . Extra-articular manifestations in 587 Italian patients with rheumatoid arthritis. Rheumatol Int. 2000; 19(6):213-7. DOI: 10.1007/pl00006853. View

19.

Melton 3rd L . History of the Rochester Epidemiology Project. Mayo Clin Proc. 1996; 71(3):266-74. DOI: 10.4065/71.3.266. View

20.

Tanaka E, Mannalithara A, Inoue E, Hara M, Tomatsu T, Kamatani N . Efficient management of rheumatoid arthritis significantly reduces long-term functional disability. Ann Rheum Dis. 2007; 67(8):1153-8. DOI: 10.1136/ard.2007.072751. View